Keto Drinks as a Meal Primer in Patients With Type 2 Diabetes
NCT ID: NCT05263401
Last Updated: 2023-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2022-01-01
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis is:
3-OHB as a pre-meal may:
* Lower postprandial blood glucose and lipids.
* Mediate release of intestinal hormones and affect gastric emptying.
* Affect appetite and other subjective measures related to food intake.
The effects of 3-OHB as a pre-meal will be investigated by blood samples, isotopic tracers examinations, paracetamol test, questionnaires and meal test.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Examining the Feasibility of Prolonged Ketone Concentrate Supplement Drink Consumption in Adults With Type 2 Diabetes
NCT05983562
Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes
NCT05477368
The Effect of a Ketone Drink on Blood Glucose Levels in People With Type 2 Diabetes
NCT06324669
Effect of Ketogenic Diet on Glucose Metabolism and Energy Expenditure in Type 2 Diabetes
NCT04791787
The Effect of a Ketone Drink on Liver Glucose Production in People With Type 2 Diabetes
NCT05518448
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ketone salt
Na-D/L-3-hydroxybutyrate dissolved in tap water.
3-hydroxybutyrate
Orally administered pre-meal drinks.
Ketone ester
(R)-3-Hydroxybutyl (R)-3-hydroxybutyrate
3-hydroxybutyrate
Orally administered pre-meal drinks.
Placebo
Tap water
3-hydroxybutyrate
Orally administered pre-meal drinks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3-hydroxybutyrate
Orally administered pre-meal drinks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HbA1C \< 80 mmol/mol
* 25 \< BMI \< 35
* Written consent
Exclusion Criteria
* Treatment with insulin, GLP-1 analogues, SGLT-2-inhibitors or sulfonylureas
* Specific diets, e.g. ketogenic diet
* PI finds the patient not fit (e.g. mental illness, too nervous, unacceptable screening blood tests or other)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aarhus University Hospital
OTHER
University of Aarhus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Niels Møller, Professor
Role: STUDY_DIRECTOR
Aarhus University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical research laboratory, Department of endocrinology, Aarhus University Hospital
Aarhus, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1-10-72-282-20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.